Eledon Pharmaceuticals, Inc. Operating Lease Right-of-Use Assets
Eledon Pharmaceuticals, Inc. (ELDN) had Operating Lease Right-of-Use Assets of $445.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $445.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $530.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $613.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $694.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $445.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $530.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $613.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $694.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $773.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $850.00K 10-Q/A · filed 2025-08-14 |
| 2024-12-31 | $926.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $471.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $621.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $270.00K 10-Q/A · filed 2024-08-19 |
| 2023-12-31 | $365.00K 10-K/A · filed 2025-08-14 |
| 2023-09-30 | $459.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $553.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $647.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $739.00K 10-K/A · filed 2024-08-19 |
| 2022-09-30 | $832.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $581.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $675.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $768.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $222.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $267.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $92.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $138.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $183.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $228.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $272.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $316.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $360.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $403.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $446.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |